Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity.

The X-ray crystallographic structure of P-30 protein (Onconase) has been solved by multiple isomorphous replacement and the structure has been refined at 1.7 A resolution to a conventional R-factor of 0.178. The molecular model comprises all 826 non-hydrogen protein atoms, 96 solvent molecules and a sulfate anion that is bound at the active site. The molecular structure is similar to that of ribonuclease A. The active site cleft is located at the junction of two three-stranded beta-sheets and the N-terminal helix. A sulfate anion is non-covalently bound by Lys9, His10, His97, Phe98 and an intermolecular contact involving Lys55' from a neighboring molecule. The N-terminal pyroglutamyl (Pyr) residue is part of the active site and its O epsilon 1 atom forms a hydrogen bond with the Lys9 N zeta. The previously constructed comparative molecular model of P-30 based on ribonuclease A correctly predicted the overall fold of P-30 and the conformation of its active site residues. The model failed to predict the conformation of Pyr1 and the conformation of the two loops following helix alpha 3 and strand beta 3.

[1]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[2]  M. James,et al.  Crystallographic analysis of transition-state mimics bound to penicillopepsin: phosphorus-containing peptide analogues. , 1993, Biochemistry.

[3]  W. Ardelt,et al.  Striking Increase of Survival of Mice Bearing M 109 Madison Carcinoma Treated With a Novel Protein From With a Novel Protein From Amphibian Embryos , 1990 .

[4]  M. Karplus,et al.  Crystallographic R Factor Refinement by Molecular Dynamics , 1987, Science.

[5]  A. Mclachlan,et al.  Repeating sequences and gene duplication in proteins. , 1972, Journal of molecular biology.

[6]  R J Read,et al.  Critical evaluation of comparative model building of Streptomyces griseus trypsin. , 1984, Biochemistry.

[7]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[8]  S. Rybak,et al.  A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity. , 1993, The Journal of biological chemistry.

[9]  S. Rybak,et al.  Comparison of RNases and toxins upon injection into Xenopus oocytes. , 1991, The Journal of biological chemistry.

[10]  Jorge Navaza,et al.  Accurate computation of the rotation matrices , 1990 .

[11]  W. Ardelt,et al.  Comparative molecular modeling and crystallization of P‐30 protein: A novel antitumor protein of Rana pipiens oocytes and early embryos , 1992, Proteins.

[12]  A Wlodawer,et al.  Structure of ribonuclease A: results of joint neutron and X-ray refinement at 2.0-A resolution. , 1982, Biochemistry.

[13]  J. Kycia,et al.  Dinitrophenylation and inactivation of bovine pancreatic ribonuclease A. , 1965, Archives of biochemistry and biophysics.

[14]  B. L. Sibanda,et al.  β-Hairpin families in globular proteins , 1985, Nature.

[15]  W. Ardelt,et al.  Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases. , 1991, The Journal of biological chemistry.

[16]  G. Tarnowski,et al.  Comparison of antitumor activities of pancreatic ribonuclease and its cross-linked dimer. , 1976, Cancer research.

[17]  S. Rybak,et al.  Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins. , 1991, The Journal of biological chemistry.

[18]  R. Hamlin,et al.  [27] Multiwire area X-ray diffractometers , 1985 .

[19]  W. Ardelt,et al.  Cytostatic and Cytotoxic Effects of Pannon (P‐30 Protein), A Novel Anticancer Agent , 1988, Cell and tissue kinetics.

[20]  E. Dodson.  Molecular replacement: The method and its problems , 1988 .

[21]  Jones Ta,et al.  Diffraction methods for biological macromolecules. Interactive computer graphics: FRODO. , 1985, Methods in enzymology.

[22]  N. Borkakoti.  The active site of ribonuclease A from the crystallographic studies of ribonuclease-A-inhibitor complexes. , 1983, European journal of biochemistry.

[23]  Protein Structure and Function by Comparative Model Building , 1985 .

[24]  M. James,et al.  Comparison of the predicted model of α-lytic protease with the X-ray structure , 1979, Nature.

[25]  R. Read.  Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[26]  Lindsay Sawyer,et al.  Carboxyl–carboxylate interactions in proteins , 1982, Nature.

[27]  W. Ardelt,et al.  Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P‐30 protein, a novel protein possessing anti‐tumour activity , 1990, Cell and tissue kinetics.

[28]  A. Wlodawer,et al.  Active site of RNase: neutron diffraction study of a complex with uridine vanadate, a transition-state analog. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Lesk,et al.  The relation between the divergence of sequence and structure in proteins. , 1986, The EMBO journal.

[30]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[31]  M. O. Dayhoff,et al.  Atlas of protein sequence and structure , 1965 .

[32]  B. Matthews.  Solvent content of protein crystals. , 1968, Journal of molecular biology.

[33]  N. Xuong,et al.  Software for a diffractometer with multiwire area detector. , 1985, Methods in enzymology.

[34]  G. D'alessio,et al.  In vitro studies on selective inhibition of tumor cell growth by seminal ribonuclease. , 1980, Cancer research.

[35]  A. Carsana,et al.  Molecular evolution of the ribonuclease superfamily. , 1988, Progress in biophysics and molecular biology.

[36]  S. Wodak.  The structure of cytidilyl(2',5')adenosine when bound to pancreatic ribonuclease S. , 1977, Journal of molecular biology.

[37]  C. Raetz,et al.  Schiff bases of pyridoxal phosphate with active center lysines of ribonuclease A. , 1972, Biochemistry.